Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Limited, a Brazil-based foreign private issuer, submitted a Form 6-K for August 2025. The filing mainly serves to furnish an exhibit titled "Afya Limited Announces a New Share Repurchase Program," indicating the company has authorized a new program to buy back its own shares. The report is signed on behalf of Afya by its Chief Executive Officer, Virgilio Deloy Capobianco Gibbon.